药物管线
我们的药物发现项目，从靶点识别到临床前开发。
KCNQ2 Anticonvulsant Program
Epilepsy (KCNQ2 mutations)
Targeted therapy for KCNQ2-related epilepsy using structure-based drug design and AI-enhanced virtual screening.
GABA-A Receptor Allosteric Modulator
Anxiety disorders
Subtype-selective allosteric modulators of GABA-A receptors with improved safety profiles.
AI-Enhanced Virtual Screening Pipeline
Generalizable platform
A generalizable computational pipeline for rapid virtual screening against emerging drug targets.